Refractory T-cell prolymphocytic leukemia with JAK3 mutation: In vitro and clinical synergy of tofacitinib and ruxolitinib Meeting Abstract
| Authors: | Wei, M.; Koshy, N.; van Besien, K.; Inghirami, G.; Horwitz, S. M. |
| Abstract Title: | Refractory T-cell prolymphocytic leukemia with JAK3 mutation: In vitro and clinical synergy of tofacitinib and ruxolitinib |
| Meeting Title: | 57th Annual Meeting of the American Society of Hematology (ASH) |
| Journal Title: | Blood |
| Volume: | 126 |
| Issue: | 23 |
| Meeting Dates: | 2015 Dec 5-8 |
| Meeting Location: | Orlando, FL |
| ISSN: | 0006-4971 |
| Publisher: | American Society of Hematology |
| Date Published: | 2015-12-03 |
| Language: | English |
| ACCESSION: | WOS:000368021805139 |
| PROVIDER: | wos |
| DOI: | 10.1182/blood.V126.23.5486.5486 |
| Notes: | Meeting Abstract: 5486 -- 57th Annual Meeting of the American-Society-of-Hematology -- DEC 05-08, 2015 -- Orlando, FL -- Source: Wos |
